Pfizer's Herceptin biosimilar succeeds in key breast cancer study The Pfizer logo is seen at their world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File photo – RTX2MJU3 Visit the Source Site Powered by WPeMatico